Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Canakinumab's effect on COVID-19 outcomes is unclear.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Certain proteins and cytokines are key in causing psoriatic skin issues.

TGF-β1 and TNF-α contribute to lung damage after radiation.

PCOS is linked to low-grade chronic inflammation.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Certain cytokines and growth factors can inhibit hair growth and may affect alopecia areata.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Interleukin-6 may play a role in causing alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

Certain cytokines and growth factors can stop hair growth and may play a role in alopecia areata.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Higher levels of certain proteins may increase or decrease rosacea risk.

Blocking interferon-gamma might help treat various autoimmune diseases.

Inflammation is linked to hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.